Industry: Biotechnology

Article

Contest Matchup #6: CRISPR Therapeutics vs Seres Therapeutics

Apr 2, 2024

Two biotech companies go head-to-head in our sixth Stockpicking matchup.

Article

3 Takeaways from the 2024 WSJ Health Forum

Feb 27, 2024

The WSJ Health Forum showcased several new technologies and industry-wide discussions. Here were three of its biggest highlights.

Article

Krystal Biotech is Soaring. But the Good Times Are Just…

Feb 26, 2024

The small-cap biotech company just reported excellent 4Q results. But there might be even more gains on the horizon.

Article

AI is Bringing Synthetic Biology Back to Life

Feb 6, 2024

New AI tools could supercharge the emerging field of generative biology. The therapeutics segment might be a natural fit.

Article

Why Seres Therapeutics is My Best Buy in January

Jan 17, 2024

The market's first microbiome company is getting a good reception to its first commercially-approved drug.

Article

Is Seres Therapeutics Preparing To Be Acquired?

Nov 3, 2023

Seres Therapeutics announced great initial sales data but also a company restructuring. Is it preparing for an upcoming acquisition?

Premium Advisor Update

That’s a Wrap for JPM23, What did We Learn?

Jan 17, 2023

Article

Seres Therapeutics: A Microbiome Leader With a Huge Upcoming Catalyst

Jan 11, 2023

Seres Therapeutics is a biotech stock for your watch list. 7investing CEO Simon Erickson describes why the pending approval of its flagship drug could be significant for investors.

Premium Advisor Update

JPM is Underway, Investor Updates and Deal-Making Galore!

Jan 10, 2023

Article

Move Over Tech, It’s Healthcare’s Week in the Spotlight

Jan 8, 2023

Las Vegas may have been buzzing (literally) with all of the latest and greatest technology at CES this past week, but those of us interested in the health care industry know to save our energy for...

Premium Advisor Update

Overcoming Some of the Complexities of Investing in Biotech

Oct 30, 2022

Article

How to Invest in Biotechnology

Oct 27, 2022

7investing's resident biotech PhD shares some valuable lessons about what to look for when investing in this space.

Premium Advisor Update

Why Simon Chose His Top Stock for October

Oct 14, 2022

Article

Simon’s Top Stock for October 2022

Oct 1, 2022

7investing Lead Advisor Simon Erickson’s Top Stock to Buy in October 2022 is a one-of-a-kind company who is on a global mission.

Article

DEI in Health Care: More Important than You Think

Sep 30, 2022

Lead Advisor Dana Abramovitz discusses the importance of diversity in clinical trials.

Article

Dana’s Top Stock for August 2022

Aug 2, 2022

7investing Lead Advisor Dana Abramovitz’s recommendation for August 2022 is health care technology company that is a first mover in a new and growing market.